Back to search

Monitoring of Immunosuppressive Therapy in Renal Transplanted Patients

Data up to Jan 2025

Published2004
Citations7
References40

Total Citations Per Year

Abstract

References (40)

Clinical Pharmacokinetics of Tacrolimus

1995 • 749 citations

MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1

1997 • 729 citations

A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1

1999 • 533 citations

Clinical Pharmacokinetics of Everolimus

2004 • 476 citations

NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVE

1999 • 399 citations

Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics

1995 • 311 citations

RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATION

1996 • 300 citations

Therapeutic drug monitoring of immunosuppressant drugs in clinical practice

2002 • 287 citations

Mycophenolate Mofetil Dose Reduction and the Risk of Acute Rejection after Renal Transplantation

2003 • 278 citations

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

2000 • 277 citations

Pharmacokinetics of Sirolimus in Stable Renal Transplant Patients after Multiple Oral Dose Administration

1997 • 212 citations

REDUCED INTER- AND INTRASUBJECT VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH A MICROEMULSION FORMULATION IN CONJUNCTION WITH FASTING, LOW-FAT MEALS, OR HIGH-FAT MEALS1,2

1995 • 202 citations

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation

2003 • 197 citations

Low systemic exposure to tacrolimus correlates with acute rejection

1999 • 183 citations

Pharmacokinetics of mycophenolate mofetil (RS61443): a short review.

1996 • 182 citations

EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1

1999 • 173 citations

Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation.

1994 • 173 citations

Mycophenolic Acid Area under the Curve Values in African American and Caucasian Renal Transplant Patients Are Comparable

2000 • 134 citations

Clinical validation studies of neoral C2 monitoring: a review

2002 • 128 citations

Therapeutic monitoring of mycophenolic acid

1998 • 127 citations

Pharmacokinetics and Concentration-Control Investigations of Mycophenolic Acid in Adults After Transplantation

2000 • 121 citations

Current opinions on therapeutic drug monitoring of immunosuppressive drugs

1999 • 115 citations

Pharmacokinetics of tacrolimus-based combination therapies

2003 • 108 citations

A PHASE I STUDY OF A 4-WEEK COURSE OF SDZ-RAD (RAD) IN QUIESCENT CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS1,2

1999 • 108 citations

Maintenance immunosuppression in the renal transplant recipient: An overview

2001 • 104 citations

Inhibition of Stimulated Interleukin-2 Production in Whole Blood: A Practical Measure of Cyclosporine Effect

1999 • 95 citations

Differential Influence of Two Cyclosporine Formulations on Everolimus Pharmacokinetics: A Clinically Relevant Pharmacokinetic Interaction

2002 • 87 citations

Pharmacokinetics of tacrolimus: clinically relevant aspects

1999 • 78 citations

Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection

1998 • 77 citations

Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving prograf and cellcept in combination therapy

1997 • 73 citations

Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children

2002 • 71 citations

Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy

2004 • 70 citations

Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration.

1997 • 63 citations

Evaluation of Limited Sampling Strategies for Estimation of 12-Hour Mycophenolic Acid Area Under the Plasma Concentration???Time Curve in Adult Renal Transplant Patients

2000 • 61 citations

Two‐hour post‐dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts

2002 • 58 citations

Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients

1999 • 35 citations

Therapeutic monitoring of sirolimus: its contribution to optimal prescription

2003 • 33 citations

C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients

2001 • 32 citations

Effect of bile flow on the absorption of tacrolimus in liver allograft transplantation

2002 • 28 citations

Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients

2004 • 25 citations

Cited By (0)

Loading...
Monitoring of Immunosuppressive Therapy in Renal Transplanted Patients (2004) – KARGER eBooks | Metascience Observatory Explorer